Celldex Therapeutics Inc (FRA:TCE2)
€ 18.6 -0.50 (-2.62%) Market Cap: 1.27 Bil Enterprise Value: 696.70 Mil PE Ratio: 0 PB Ratio: 2.11 GF Score: 58/100

Celldex Therapeutics Inc (FRA:TCE2) Transcripts

  • 1